Anti-Prion protein PrP antibody [8H4] (ab61409)
Key features and details
- Mouse monoclonal [8H4] to Prion protein PrP
- Suitable for: IP, Indirect ELISA, WB, ICC, IHC-P, Flow Cyt
- Reacts with: Mouse, Rat, Sheep, Cow, Human, Monkey
- Isotype: IgG2b
Overview
-
Product name
Anti-Prion protein PrP antibody [8H4]
See all Prion protein PrP primary antibodies -
Description
Mouse monoclonal [8H4] to Prion protein PrP -
Host species
Mouse -
Tested applications
Suitable for: IP, Indirect ELISA, WB, ICC, IHC-P, Flow Cytmore details -
Species reactivity
Reacts with: Mouse, Rat, Sheep, Cow, Human, Monkey -
Immunogen
Recombinant full length protein corresponding to Mouse Prion protein PrP.
Database link: P04156 -
Epitope
The antibody epitope resides within amino acids 145-180 of human Prion protein PrP. -
Positive control
- Mouse brain extract
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. -
Storage buffer
pH: 7.40
Preservative: 0.097% Sodium azide
Constituent: 0.0268% PBS -
Concentration information loading...
-
Purity
IgG fraction -
Purification notes
Purified Immunoglobulin -
Clonality
Monoclonal -
Clone number
8H4 -
Myeloma
Sp2/0 -
Isotype
IgG2b -
Research areas
Associated products
-
Compatible Secondaries
-
Conjugation kits
-
Isotype control
-
Recombinant Protein
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab61409 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
IP |
Use at an assay dependent concentration.
|
|
Indirect ELISA |
Use at an assay dependent concentration.
|
|
WB | (3) |
Use at an assay dependent concentration.
|
ICC |
Use at an assay dependent concentration.
|
|
IHC-P |
Use at an assay dependent concentration.
|
|
Flow Cyt |
Use at an assay dependent concentration.
ab170192 - Mouse monoclonal IgG2b, is suitable for use as an isotype control with this antibody. |
Notes |
---|
IP
Use at an assay dependent concentration. |
Indirect ELISA
Use at an assay dependent concentration. |
WB
Use at an assay dependent concentration. |
ICC
Use at an assay dependent concentration. |
IHC-P
Use at an assay dependent concentration. |
Flow Cyt
Use at an assay dependent concentration. ab170192 - Mouse monoclonal IgG2b, is suitable for use as an isotype control with this antibody. |
Target
-
Function
The function of PrP is still under debate. May play a role in neuronal development and synaptic plasticity. May be required for neuronal myelin sheath maintenance. May play a role in iron uptake and iron homeostasis (By similarity). Isoform 2 may act as a growth suppressor by arresting the cell cycle at the G0/G1 phase. Soluble oligomers are toxic to cultured neuroblastoma cells and induce apoptosis (in vitro). -
Involvement in disease
Note=PrP is found in high quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases, like: Creutzfeldt-Jakob disease (CJD), fatal familial insomnia (FFI), Gerstmann-Straussler disease (GSD), Huntington disease-like type 1 (HDL1) and kuru in humans; scrapie in sheep and goat; bovine spongiform encephalopathy (BSE) in cattle; transmissible mink encephalopathy (TME); chronic wasting disease (CWD) of mule deer and elk; feline spongiform encephalopathy (FSE) in cats and exotic ungulate encephalopathy (EUE) in nyala and greater kudu. The prion diseases illustrate three manifestations of CNS degeneration: (1) infectious (2) sporadic and (3) dominantly inherited forms. TME, CWD, BSE, FSE, EUE are all thought to occur after consumption of prion-infected foodstuffs.
Defects in PRNP are the cause of Creutzfeldt-Jakob disease (CJD) [MIM:123400]. CJD occurs primarily as a sporadic disorder (1 per million), while 10-15% are familial. Accidental transmission of CJD to humans appears to be iatrogenic (contaminated human growth hormone (HGH), corneal transplantation, electroencephalographic electrode implantation, etc.). Epidemiologic studies have failed to implicate the ingestion of infected annimal meat in the pathogenesis of CJD in human. The triad of microscopic features that characterize the prion diseases consists of (1) spongiform degeneration of neurons, (2) severe astrocytic gliosis that often appears to be out of proportion to the degree of nerve cell loss, and (3) amyloid plaque formation. CJD is characterized by progressive dementia and myoclonic seizures, affecting adults in mid-life. Some patients present sleep disorders, abnormalities of high cortical function, cerebellar and corticospinal disturbances. The disease ends in death after a 3-12 months illness.
Defects in PRNP are the cause of fatal familial insomnia (FFI) [MIM:600072]. FFI is an autosomal dominant disorder and is characterized by neuronal degeneration limited to selected thalamic nuclei and progressive insomnia.
Defects in PRNP are the cause of Gerstmann-Straussler disease (GSD) [MIM:137440]. GSD is a heterogeneous disorder and was defined as a spinocerebellar ataxia with dementia and plaquelike deposits. GSD incidence is less than 2 per 100 million live births.
Defects in PRNP are the cause of Huntington disease-like type 1 (HDL1) [MIM:603218]. HDL1 is an autosomal dominant, early onset neurodegenerative disorder with prominent psychiatric features.
Defects in PRNP are the cause of kuru (KURU) [MIM:245300]. Kuru is transmitted during ritualistic cannibalism, among natives of the New Guinea highlands. Patients exhibit various movement disorders like cerebellar abnormalities, rigidity of the limbs, and clonus. Emotional lability is present, and dementia is conspicuously absent. Death usually occurs from 3 to 12 month after onset.
Defects in PRNP are the cause of spongiform encephalopathy with neuropsychiatric features (SENF) [MIM:606688]; an autosomal dominant presenile dementia with a rapidly progressive and protracted clinical course. The dementia was characterized clinically by frontotemporal features, including early personality changes. Some patients had memory loss, several showed aggressiveness, hyperorality and verbal stereotypy, others had parkinsonian symptoms. -
Sequence similarities
Belongs to the prion family. -
Domain
The normal, monomeric form has a mainly alpha-helical structure. The disease-associated, protease-resistant form forms amyloid fibrils containing a cross-beta spine, formed by a steric zipper of superposed beta-strands. Disease mutations may favor intermolecular contacts via short beta strands, and may thereby trigger oligomerization.
Contains an N-terminal region composed of octamer repeats. At low copper concentrations, the sidechains of His residues from three or four repeats contribute to the binding of a single copper ion. Alternatively, a copper ion can be bound by interaction with the sidechain and backbone amide nitrogen of a single His residue. The observed copper binding stoichiometry suggests that two repeat regions cooperate to stabilize the binding of a single copper ion. At higher copper concentrations, each octamer can bind one copper ion by interactions with the His sidechain and Gly backbone atoms. A mixture of binding types may occur, especially in the case of octamer repeat expansion. Copper binding may stabilize the conformation of this region and may promote oligomerization. -
Post-translational
modificationsThe glycosylation pattern (the amount of mono-, di- and non-glycosylated forms or glycoforms) seems to differ in normal and CJD prion.
Isoform 2 is sumoylated by SUMO1. -
Cellular localization
Cell membrane. Golgi apparatus and Cytoplasm. Nucleus. Accumulates outside the secretory route in the cytoplasm, from where it relocates to the nucleus. - Information by UniProt
-
Database links
- Entrez Gene: 281427 Cow
- Entrez Gene: 5621 Human
- Entrez Gene: 19122 Mouse
- Entrez Gene: 24686 Rat
- Entrez Gene: 493887 Sheep
- Omim: 176640 Human
- SwissProt: P10279 Cow
- SwissProt: P04156 Human
see all -
Alternative names
- Alternative prion protein; major prion protein antibody
- AltPrP antibody
- ASCR antibody
see all
Images
-
Anti-Prion protein PrP antibody [8H4] (ab61409) at 4 µg/ml + Mouse brain extract
Secondary
Goat Anti-Mouse IgG-Peroxidase -
All lanes : Anti-Prion protein PrP antibody [8H4] (ab61409) at 1/2500 dilution
Lane 1 : Wild type mouse hippocampus whole tissue lysate
Lane 2 : Prnp-/- mouse hippocampus whole tissue lysate
Lysates/proteins at 30 µg per lane.
Secondary
All lanes : HRP-conjugated sheep anti-mouse IgG monoclonal at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Observed band size: 25-37 kDa why is the actual band size different from the predicted?
Exposure time: 30 seconds
Protocols
Datasheets and documents
-
SDS download
-
Datasheet download
References (11)
ab61409 has been referenced in 11 publications.
- Mortberg MA et al. Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS. JCI Insight 7:N/A (2022). PubMed: 35133987
- Miranzadeh Mahabadi H et al. Cannabinoid receptors distribution in mouse cortical plasma membrane compartments. Mol Brain 14:89 (2021). PubMed: 34099009
- Gunther EC et al. Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists. Cell Rep 26:145-158.e8 (2019). PubMed: 30605671
- Wiegmans AP et al. Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer. JCI Insight 5:N/A (2019). PubMed: 30830863
- Omae Y et al. Integrative genome analysis identified the KANNO blood group antigen as prion protein. Transfusion N/A:N/A (2019). PubMed: 31020675